The US Food and Drug Administration and the Federal Communications Commission have formed an initiative to improve the efficiency of their respective regulatory processes applicable to broadband and wireless-enabled medical devices1.
The agencies have signed a joint statement of principles2 and a memorandum of understanding3 that will, among other things, increase the regulatory predictability for providers of broadband and wireless-enabled medical devices and improve their understanding of regulatory requirements for such products...
Please login to read the full article.
